Zoxaphen K (325+250+50) Tablet | Price, Usage, Dosage, Composition, and Brand Substitutes - Fixed-Dose Combination (FDC) Drug
Zoxaphen K (325+250+50) Tablet
Zoxaphen K (325+250+50) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Chemo Drugs. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Paracetamol, Chlorzoxazone,Diclofenac Potassium. This drug comes in the form of Tablet. The general packing available for this medicine consists of 10 Tablet and is priced at Rs 39 (arround $0.546 US Dollar)| Generic (Salt) Combination : | (Paracetamol+ Chlorzoxazone+Diclofenac Potassium) |
| Pharma Company : | Chemo Drugs |
| Brand Label : | Zoxaphen K (325+250+50) |
| Preparation Type : | Tablet |
| Single Dose : | 1 Tablet |
| Composition (Fixed-Dose Combination) : |
|
| Pack Size/Qty/Vol : | 10 Tablet |
| Price Unit : | Rs 3.9 INR (arround $0.0546 US Dollar) |
| Price Pack : | Rs 39 INR (arround $0.546 US Dollar) |
Drug details for Zoxaphen K (325+250+50)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Zoxaphen K (325+250+50) are :
Paracetamol
Indication (Prescribed for or used as): Analgesic and antipyretic.
For more details on Paracetamol, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Paracetamol..
ChlorzoxazoneIndication (Prescribed for or used as): Chlorzoxazone is used to relieve pain and stiffness caused by muscle strains and sprains. It is used in combination with physical therapy, analgesics (such as aspirin or acetaminophen), and rest.Skeletal muscle spasms.
For more details on Chlorzoxazone, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Chlorzoxazone..
Diclofenac PotassiumIndication (Prescribed for or used as):
For more details on Diclofenac Potassium, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Diclofenac Potassium..
Zoxaphen K (325+250+50) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 6 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Zoxaphen K (325+250+50), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Diclofenac Potassium-50 mg Chlorzoxazone-250 mg Paracetamol-325 mg).Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.
| Brand | Price (Rs.) | Brand | Price (Rs.) |
| Chlorizok (325+250+50) | 45 | Dicnak MR (325+250+50) | 27 |
| Diczone Plus (325+250+50) | 40 | Loco MR (325+250+50) | 37 |
| Mobigesic (325+250+50) | 36 | Zone MR (325+250+50) | 65 |
Zoxaphen K (325+250+50) Tablet
Zoxaphen K (325+250+50) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Chemo Drugs. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Chlorzoxazone, Diclofenac Potassium,Paracetamol. This drug comes in the form of Tablet. The general packing available for this medicine consists of 10 Tablet and is priced at Rs 39 (arround $0.546 US Dollar)| Generic (Salt) Combination : | (Chlorzoxazone+ Diclofenac Potassium+Paracetamol) |
| Pharma Company : | Chemo Drugs |
| Brand Label : | Zoxaphen K (325+250+50) |
| Preparation Type : | Tablet |
| Single Dose : | 1 Tablet |
| Composition (Fixed-Dose Combination) : |
|
| Pack Size/Qty/Vol : | 10 Tablet |
| Price Unit : | Rs 3.9 INR (arround $0.0546 US Dollar) |
| Price Pack : | Rs 39 INR (arround $0.546 US Dollar) |
Drug details for Zoxaphen K (325+250+50)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Zoxaphen K (325+250+50) are :
Chlorzoxazone
Indication (Prescribed for or used as): Chlorzoxazone is used to relieve pain and stiffness caused by muscle strains and sprains. It is used in combination with physical therapy, analgesics (such as aspirin or acetaminophen), and rest.
For more details on Chlorzoxazone, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Chlorzoxazone..
Diclofenac PotassiumIndication (Prescribed for or used as):
For more details on Diclofenac Potassium, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Diclofenac Potassium..
ParacetamolIndication (Prescribed for or used as): Analgesic and antipyretic.
For more details on Paracetamol, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Paracetamol..
Zoxaphen K (325+250+50) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 84 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Zoxaphen K (325+250+50), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Paracetamol-325 mg Chlorzoxazone-250 mg Diclofenac Potassium-50 mg).Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.